On Monday, Twist Bioscience Corp (NASDAQ: TWST) was 6.02% up from the session before settling in for the closing price of $29.30. A 52-week range for TWST has been $27.12 – $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 41.91%. When this article was written, the company’s average yearly earnings per share was at 40.93%. With a float of $56.68 million, this company’s outstanding shares have now reached $59.86 million.
Let’s determine the extent of company efficiency that accounts for 923 employees. In terms of profitability, gross margin is 46.7%, operating margin of -57.86%, and the pretax margin is -55.03%.
Twist Bioscience Corp (TWST) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Twist Bioscience Corp stocks. The insider ownership of Twist Bioscience Corp is 5.40%, while institutional ownership is 110.03%. The most recent insider transaction that took place on May 23 ’25, was worth 23,264. In this transaction Chief Accounting Officer of this company sold 839 shares at a rate of $27.73, taking the stock ownership to the 50,191 shares. Before that another transaction happened on May 21 ’25, when Company’s insider sold 531 for $29.75, making the entire transaction worth $15,796. This insider now owns 105,318 shares in total.
Twist Bioscience Corp (TWST) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 40.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.71% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
You can see what Twist Bioscience Corp (TWST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Looking closely at Twist Bioscience Corp (NASDAQ: TWST), its last 5-days average volume was 1.36 million, which is a jump from its year-to-date volume of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 61.61%. Additionally, its Average True Range was 2.18.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 13.98%, which indicates a significant decrease from 61.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.41% in the past 14 days, which was lower than the 69.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.73, while its 200-day Moving Average is $42.69. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $32.12. Second resistance stands at $33.18. The third major resistance level sits at $34.58. If the price goes on to break the first support level at $29.66, it is likely to go to the next support level at $28.25. Should the price break the second support level, the third support level stands at $27.20.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are 59,916K outstanding shares of the company, which has a market capitalization of 1.86 billion. As of now, sales total 312,970 K while income totals -208,730 K. Its latest quarter income was 92,790 K while its last quarter net income were -39,330 K.
